Adgero Biopharmaceuticals Holdings, Inc. Contracts & Agreements

45 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amendment to Registration Rights Agreement
Registration Rights Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Employment Agreement, dated October 11, 2017, between the Company and John Liatos
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Warrant Agent Agreement, dated August 14, 2017, between the Company and Aegis Capital Corp
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Employment Agreement, dated September 1, 2017, between the Company and Felix Garzon
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NJ
2017
FIRST AMENDMENT TO THE ADGERO BIOPHARMACEUTICALS HOLDINGS, INC. 2016 EQUITY INCENTIVEPLAN
Adgero Biopharmaceuticals Holdings, Inc.
2017
AGREEMENT AND PLAN OF MERGER by and among ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., ADGERO ACQUISITION, INC., ADGEROBIOPHARMACEUTICALS,INC. and FRANK G. PILKIEWICZ, as the...
Merger Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Replacement Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Investor Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Placement Agent Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Registration Rights Agreement
Registration Rights Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of August Investor Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Common Stock Certificate
Stock Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of December 2016 Investor Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Placement Agency Agreement, dated January 11, 2016, between the Company and Aegis Capital Corp
Agency Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Subscription Agreement for the Companys 2016 private placement
Subscription Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Voting Agreement, dated April 8, 2016, by and among the Company and the stockholders named therein
Voting Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
2016 Equity Incentive Plan
Bonus & Incentive Agreements
Adgero Biopharmaceuticals Holdings, Inc.
DE
2017
Form of Incentive Stock Option Agreement
Bonus & Incentive Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Non-Qualified Stock Option Agreement
Stock Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Restricted Stock Agreement
Stock Agreements
Adgero Biopharmaceuticals Holdings, Inc.
DE
2017
Employment Agreement, dated April 8, 2016, between the Company and Frank Pilkiewicz, PhD
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NJ
2017
Employment Agreement, dated April 8, 2016, between the Company and Steven Rychnovsky, PhD
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Subscription Agreement for the Companys August private placement
Subscription Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Promissory Note, dated July 9, 2014, among Adgero Biopharmaceuticals, Inc. and Frank Pilkiewicz, PhD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Amendment to Promissory Note, dated December 30, 2015, among Adgero Biopharmaceuticals, Inc. and Frank Pilkiewicz, PhD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Asset Purchase Agreement, dated as of November 26, 2012, among Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC
Purchase Agreements
Adgero Biopharmaceuticals Holdings, Inc.
DE
2017
Amendment to Asset Purchase Agreement, dated May 12, 2014, among Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC
Purchase Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
6% Convertible Note, dated October 6, 2015, among Adgero Biopharmaceuticals, Inc. and Robert F. Hendrickson
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Amendment to 6% Convertible Note, dated March 25, 2016, among Adgero Biopharmaceuticals, Inc. and Robert F. Hendrickson
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
6% Convertible Note, dated October 28, 2015, among Adgero Biopharmaceuticals, Inc. and Roman Perez-Soler, MD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Amendment to 6% Convertible Note, dated March 28, 2016, among Adgero Biopharmaceuticals, Inc. and Roman Perez-Soler, MD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
6% Convertible Note, dated December 23, 2015, among Adgero Biopharmaceuticals, Inc. and Adam Stern
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Amendment to 6% Convertible Note, dated March 21, 2016, among Adgero Biopharmaceuticals, Inc. and Adam Stern
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Engagement Letter, dated August 8, 2016, between the Company and Aegis Capital Corporation
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
8% Convertible Note, dated November 26, 2012, among Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
8% Convertible Note, dated November 26, 2012, among Adgero Biopharmaceuticals, Inc. and Steven Rychnovsky, PhD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Indemnification Agreement
Indemnification Agreements
Adgero Biopharmaceuticals Holdings, Inc.
DE
2017
Employment Agreement, dated October 3, 2016, between the Company and Laura Pflug
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NJ
2017
Agreement of Lease, dated November 8, 2016, between the Company and Sutman Princeton Associates, L.P
Lease Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Lease Modification Agreement, dated November 8, 2016, between the Company and Sutman Princeton Associates, L.P
Lease Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Employment Agreement, dated April 8, 2016, between the Company and Jane Maida
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NJ
2017
Amendment No. 1 to Employment Agreement, dated February 8, 2017, between the Company and Frank Pilkiewicz, PhD
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Amendment No. 1 to Employment Agreement, dated February 8, 2017, between the Company and Steven Rychnovsky, PhD
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Amendment No. 1 to Employment Agreement, dated February 8, 2017, between the Company and Laura Pflug
Employment Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of Subscription Agreement for the Company's December 2016 Private Placement
Subscription Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017